MannKind (MNKD): Q3 EPS of -$0.42 beats by $0.06, on no revenue. "While we continue to be fully...

|About: MannKind Corporation (MNKD)|By:, SA News Editor
MannKind (MNKD): Q3 EPS of -$0.42 beats by $0.06, on no revenue. "While we continue to be fully engaged in the task of navigating our NDA through the FDA review process, we are continuing to run additional studies of AFRESA." Shares +1.5% AH. (PR)